Carbetocin, a long-acting oxytocin analog, shows potential to reduce blood loss during hysteroscopic myomectomy
Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy
Abstract
Carbetocin, a long-acting oxytocin analog, is proposed to reduce significant intraoperative blood loss during hysteroscopic myomectomy by inducing sustained uterine contractions.